Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
Abattis Bioceuticals (ATTBF) Stock Price & Analysis
172 Followers
ATTBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume35.00K
Average Volume (3M)N/A
Market Cap
$476.00
Enterprise Value-$1.94M
Total Cash (Recent Filing)C$2.40M
Total Debt (Recent Filing)C$150.86K
Price to Earnings (P/E)―
Beta49.69
Next Earnings
Oct 14, 2020EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding477,804,139
10 Day Avg. Volume2,357
30 Day Avg. VolumeN/A
Standard Deviation18.05
R-Squared0.02
Alpha4.09
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.00100
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
10.23%
Insiders
0.00% Mutual Funds
0.02% Other Institutional Investors
89.75% Public Companies and
Individual Investors
ATTBF FAQ
What was Abattis Bioceuticals Corp’s price range in the past 12 months?
Currently, no data Available
What is Abattis Bioceuticals Corp’s market cap?
Currently, no data Available
When is Abattis Bioceuticals Corp’s upcoming earnings report date?
Abattis Bioceuticals Corp’s upcoming earnings report date is Oct 14, 2020 which is 1373 days ago.
How were Abattis Bioceuticals Corp’s earnings last quarter?
Currently, no data Available
Is Abattis Bioceuticals Corp overvalued?
According to Wall Street analysts Abattis Bioceuticals Corp’s price is currently Overvalued.
Does Abattis Bioceuticals Corp pay dividends?
Abattis Bioceuticals Corp does not currently pay dividends.
What is Abattis Bioceuticals Corp’s EPS estimate?
Abattis Bioceuticals Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abattis Bioceuticals Corp have?
Abattis Bioceuticals Corp has 476,054,140 shares outstanding.
What happened to Abattis Bioceuticals Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Abattis Bioceuticals Corp?
Currently, no hedge funds are holding shares in ATTBF
---
Company Description
Abattis Bioceuticals Corp
Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. It produces, markets, and licenses proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic, and animal nutrition markets. The company was founded on June 30, 1997 and is headquartered in Vancouver, Canada.
---
---